Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
Erie IndemnityRyan Specialty

Erie Indemnity vs Ryan Specialty

This page compares Erie Indemnity and Ryan Specialty, examining business models, financial performance, and market context in a neutral, accessible way. It presents clear, non-promotional information ...

Investment Analysis

Pros

  • Erie Indemnity showed robust Q3 2025 financial performance with net income increasing 14% year-over-year and operating income rising 16%.
  • The company strengthened its policyholder surplus to $9.6 billion in 2025, improving financial stability and reserves.
  • Erie Indemnity delivered a positive earnings per share (EPS) surprise, reporting $3.50 versus the forecast of $3.34.

Considerations

  • The company slightly missed revenue expectations in Q3 2025, generating $1.07 billion versus a $1.08 billion forecast.
  • Erie Indemnity faces ongoing challenges from severe weather events and increasing claim severity, impacting underwriting results.
  • Valuation analysis suggests the stock may be overvalued by about 28%, implying limited margin for error at current prices.

Pros

  • Ryan Specialty Holdings reported strong Q3 2025 revenue growth of 25% year-over-year, driven by 15% organic growth and 10% from acquisitions.
  • The company is pursuing an ambitious margin expansion strategy targeting 35% adjusted EBITDAC margin by 2027 through cost management.
  • Ryan Specialty operates across diverse international markets, offering a broad range of specialty insurance services enhancing growth potential.

Considerations

  • Ryan Specialty’s trailing twelve-month earnings per share (EPS) is negative at -0.10, reflecting current profitability challenges.
  • The company carries a very high price-to-earnings ratio of 258x, indicating a richly valued stock with expectations for high future growth.
  • Competitive pressures in the specialty insurance market could challenge Ryan Specialty’s execution on growth and margin improvement plans.

Related Market Insights

Insurance Consolidation: The Next Takeover Targets

Explore the insurance consolidation wave. Sompo's Aspen deal signals prime takeover targets in specialty insurance. Discover investment opportunities in Ryan Specialty, RenaissanceRe, & Greenlight Capital Re on Nemo.

Author avatar

Aimee Silverwood | Financial Analyst

August 28, 2025

Read Insight

Which Baskets Do They Appear In?

Insurance Consolidation: The Next Takeover Targets

Insurance Consolidation: The Next Takeover Targets

Sompo Holdings' $3.5 billion acquisition of Aspen Insurance highlights a major consolidation trend in the global specialty insurance market. This theme focuses on other specialty insurers and reinsurers that may become the next acquisition targets in a rapidly consolidating industry.

Published: August 28, 2025

Explore Basket

Buy ERIE or RYAN in Nemo

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Erie IndemnityEquitable

Erie Indemnity vs Equitable

Erie Indemnity vs Equitable: A stock comparison

Erie IndemnitySantander Chile

Erie Indemnity vs Santander Chile

Erie Indemnity vs Santander Chile

Erie IndemnityBancolombia

Erie Indemnity vs Bancolombia

Erie Indemnity vs Bancolombia

Frequently asked questions